Towards Novel Biomimetic In Vitro Models of the Blood–Brain Barrier for Drug Permeability Evaluation
Bioengineering · 10.05.2023 · 10 (5) · 572
DOI: 10.3390/bioengineering10050572 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 10.05.2023. Verfasst von Inés Mármol und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Microenvironment (TME) Lab, Aragón Institute of Engineering Research (I3A), University of Zaragoza, 50018 Zaragoza, Spain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIME H2020-FETOPEN-2018-2019-2020-01, M4M: MOORE4MEDICAL H2020-EU.2.1.1.7. - ECSEL, CISTEM H2020-MSCA-RISE-201.
Abstract (Originalsprache)
Current available animal and in vitro cell-based models for studying brain-related pathologies and drug evaluation face several limitations since they are unable to reproduce the unique architecture and physiology of the human blood–brain barrier. Because of that, promising preclinical drug candidates often fail in clinical trials due to their inability to penetrate the blood–brain barrier (BBB). Therefore, novel models that allow us to successfully predict drug permeability through the BBB would accelerate the implementation of much-needed therapies for glioblastoma, Alzheimer’s disease, and further disorders. In line with this, organ-on-chip models of the BBB are an interesting alternative to traditional models. These microfluidic models provide the necessary support to recreate the architecture of the BBB and mimic the fluidic conditions of the cerebral microvasculature. Herein, the most recent advances in organ-on-chip models for the BBB are reviewed, focusing on their potential to provide robust and reliable data regarding drug candidate ability to reach the brain parenchyma. We point out recent achievements and challenges to overcome in order to advance in more biomimetic in vitro experimental models based on OOO technology. The minimum requirements that should be met to be considered biomimetic (cellular types, fluid flow, and tissular architecture), and consequently, a solid alternative to in vitro traditional models or animals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tissue Microenvironment (TME) Lab, Aragón Institute of Engineering Research (I3A), University of Zaragoza, 50018 Zaragoza, Spain.
- Institute for Health Research Aragón (IIS Aragón), 50009 Zaragoza, Spain.
- Department of Dermatology, Department of Biomedical Engineering, and Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
- CIBER Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Inés Mármol, Sara Oliván
Förderung
- PRIME H2020-FETOPEN-2018-2019-2020-01
- M4M: MOORE4MEDICAL H2020-EU.2.1.1.7. - ECSEL
- CISTEM H2020-MSCA-RISE-201
- Ministry of Economy, Industry and Competitiveness
- European Union’s Horizon 2020 research and innovation programme
- Spanish Government by a research grant from them: MINECO fellowship
- Ministerio de Ciencia e Innovación and Agencia Estatal de Investigación 10.13039/501100011033 for Juan de la Cierva-Formación research contract ref
- MCIN/AEI/10.13039/501100011033 and Unión Europea NextGenerationEU/PRTR
Zitieren
APA
Mármol, I., Abizanda-Campo, S., Ayuso, J. M., Ochoa, I., & Oliván, S. (2023). Towards Novel Biomimetic In Vitro Models of the Blood–Brain Barrier for Drug Permeability Evaluation. Bioengineering, 10(5), 572. https://doi.org/10.3390/bioengineering10050572
Vancouver
Mármol I, Abizanda-Campo S, Ayuso JM, Ochoa I, Oliván S. Towards Novel Biomimetic In Vitro Models of the Blood–Brain Barrier for Drug Permeability Evaluation. Bioengineering. 2023;10(5):572. doi:10.3390/bioengineering10050572
BibTeX
@article{Mrmol2023,
author = {Mármol, Inés and Abizanda-Campo, Sara and Ayuso, Jose M and Ochoa, Ignacio and Oliván, Sara},
title = {Towards Novel Biomimetic In Vitro Models of the Blood–Brain Barrier for Drug Permeability Evaluation},
journal = {Bioengineering},
year = {2023},
volume = {10},
number = {5},
pages = {572},
doi = {10.3390/bioengineering10050572}
}
EUVIMED